2M BioTech (Claria Bioscience)

2M Biotech is a family office investment vehicle founded in 29 and based in Dallas Texas. The firm manages an evergreen structure and is looking to make equity investments into companies ranging from $.5 ? $5 million with a preference for the middle of that range. The firm is also willing to co-invest with investors they either know well or are able to get a strong reference for. The firm looks to invest in Seed and Series A rounds and looks to take a significant stake in the company?s equity. The firm prefers to invest in companies that are not located in an areas highly saturated with venture capital. The firm plans to make 3-4 new investments over the next 12 months.
Melissa Krauth
Principal 

AbbVie

AbbVie was founded by Abbott Laboratories in 213 and is based in Chicago IL. The firm partners with developmental-stage biotech companies and is actively seeking to in-license therapeutic assets. AbbVie generally seeks global rights to assets and will consider partnerships worldwide, the firm licenses assets opportunistically with no set rate of allocations. AbbVie also has a venture arm that makes equity investments AbbVie Venture & Early-Stage Collaborations.
Kevin Lynch
Vice President Search and Evaluation 

Addario Lung Cancer Medical Institute United States

The Addario Lung Cancer Medical Institute (ALCMI), founded in 2008 as a 501c(3) non-profit organization, is a patient-centric, international research consortium driving research otherwise not possible, evidenced by ALCMI's current clinical studies CASTLE, INHERIT EGFR T790M, Genomics of Young Lung Cancer and others. ALCMI overcomes barriers to collaboration via a world-class team of investigators from 21+ institutions in the U.S., France, Italy, Spain and U.K., supported by dedicated research infrastructures such as centralized project management, tissue banks and data systems. ALCMI directly facilitates research by combining scientific expertise found at leading academic institutions with patient access through our network of community cancer centers – accelerating novel research advancements to lung cancer patients. 

Mr Steven Young
Mr Steven Young
LinkedIn logo President & COO 
BIO

Steven W. Young serves as the President & Chief Operating Officer of the Addario Lung Cancer Medical Institute, a patient-founded/-focused non-profit research consortium directly linking more than 20 academic and community centers via shared infrastructures (biorepository, data system) and centrally managed intramural translational projects in the United States, France, Italy and Spain.  After transitioning from the clinical research information technology industry, Mr. Young had played a central role in the development and evolution of the Multiple Myeloma Research Consortium as its Executive Director from 2003 through 2008.  Earlier still, he served as Director of the National Institutes of Health-funded General Clinical Research Center at Mount Sinai School of Medicine and the Pediatric Clinical Research Center at Cornell University College of Medicine, both in New York City.  Mr. Young resides in Weston, Connecticut with his wife and two sons.

Advent Life Sciences United Kingdom

Advent Life Sciences

We invest predominantly in early and mid-stage life sciences companies.  We seek to back truly innovative companies that have a first-in-class or best-in-class approach and who are looking for a well-connected partner on the road to success.

Our investments cover a range of sectors within life sciences, including new drug discovery, enabling technologies, med tech and diagnostics.Advent Life Sciences is one of Europe’s leading venture teams investing in life sciences businesses. We are a deliberately small, and highly focused team of senior individuals, with long-standing track records of entrepreneurial and investment success across the UK, Europe and the USA.

Real people. Real insight. Real value.

Innovation. Clarity. Execution.

 

 


Dr Dale Pfost
Dr Dale Pfost
LinkedIn logo General Partner 

AFH Holding & Advisory

AFH Holding & Advisory LLC is a boutique investment banking firm that offers financial advisory services. The firm focuses on alternative public offerings marketing strategy planning capital structuring and mergers and acquisitions advisory. Its clientele include Carlisi Natural Gas Inc. Fossil Energy Group LLC Kaikai Technology Co. Ltd. and Yi Xin Copper Co. Ltd. AFH Holding & Advisory LLC is based in Beverly Hills California with an additional office in Pudong China.
Amir Heshmatpour
Founder & Managing Director 

Aisling Capital

Aisling Capital is a private equity group based in New York with over $1.6 billion in assets under management. Aisling is currently looking for new firms for potential investments for the firm?s third fund. The firm looks to make investments in companies seeking to raise a total round of $2-5 million. The firm looks to invest in companies globally with a focus on companies located in the United States.
Dennis Purcell
Founder and Senior Advisor 

American Heart Association

The American Heart Association is a non-profit foundation that was founded 1924. The firm looks to make equity investments into companies of up to $25 generally in the seed or series A stage. The firm is looking to invest in companies located throughout the United States and is currently seeking new investment opportunities.
Website:
www.heart.org
Investor Type
Biotech Subsector
Biotech Phase of Development
Medtech Phase of Development
Capital Structure Preference
Investment Stage Preference
Ross Tonkens
Director Science and Technology Accelerator 

Antibody Solutions United States

Antibody Solutions is a premier developer of therapeutic, diagnostic and critical reagent antibodies. Our platforms include human antibodies from transgenic OmniRats™, Hybridoma Libraries™, and high-throughput flow-cytometry screening of cell-associated targets. We provide full technical support and project management with all services performed in the USA. 

Website:
www.antibody.com
Year Founded
1995
Service Provider Type
Medtech Subsector
Biotech Phase of Development
Unique Capabilities

Human Ab producing OmniRats™ 

Hybridoma Libraries™  

High-throughput flow-cytometry screening 

Proven record of success

In Vitro Ab Production

Proven track record of success

John Kenney
President 

Apple Tree Partners United States

Apple Tree Partners is a private equity fund that was established in 1999 and based in New York, NY, with satellite offices in Princeton, NJ, Cambridge, MA and Brussels, Belgium. The firm controls up to $1.75 billion in assets under management and makes equity investments ranging from $100,000 for academic spinouts to $150 million dollar in later stage deals. The firm seeks to make investments around the globe with a focus on creating and building companies located within the US and Europe.

Year Founded
1999
Investor Type
Biotech Phase of Development
Medtech Phase of Development
Capital Structure Preference
Investment Stage Preference
Sam Hall
Principal 
Aaron Kantoff
Vice President